Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 745 in Age-associated Muscle Loss
NCT00975104Phase 2Withdrawn
- Sponsor
- Amgen
- Start
- Apr 2010
- Primary completion
- May 2011
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 2 trial of PINTA 745 in Sarcopenia, sponsored by Amgen. Planned start Apr 2010; status: withdrawn.
02
Drugs
PINTA 745
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT00975104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975104.